Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|April 4, 2022
The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple MyelomaArianna Brevi, Laura Lucia Cogrossi, Marco Lorenzoni, et al.
Blood|January 15, 2005
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responsesSara Muraro, Attilio Bondanza, Matteo Bellone, et al.
Pharmacological Research|May 24, 2016
Long non-coding RNAs as novel therapeutic targets in cancerGiovanni Lavorgna, Riccardo Vago, Mohamad Sarmini, et al.
Leukemia|March 30, 2023
Dietary and microbiome evidence in multiple myeloma and other plasma cell disordersUrvi A Shah, Richa Parikh, Francesca Castro, et al.
Oncoimmunology|November 19, 2013
Tumor-targeting vaccination instructs graft-vs.-tumor immune responsesTeresa Manzo, Rodrigo Hess Michelini, Tabea Sturmheit, et al.
Oncoimmunology|March 14, 2013
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitorsMatteo Bellone, Arianna Calcinotto, Paola Filipazzi, et al.
Cancer Research|March 1, 2018
Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and MetastasizationCarlo Sorrentino, Stefania L Ciummo, Giuseppe Cipollone, et al.
Journal of Neuroimmunology|February 13, 2010
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulationMarianna Esposito, Francesca Ruffini, Matteo Bellone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responsesGiandomenica Iezzi, Andrea Boni, Elena Degl'Innocenti, et al.
Cancer Research|July 4, 2003
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytesAnnalisa Camporeale, Andrea Boni, Giandomenica Iezzi, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|April 4, 2022
The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple MyelomaArianna Brevi, Laura Lucia Cogrossi, Marco Lorenzoni, et al.
Blood|January 15, 2005
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responsesSara Muraro, Attilio Bondanza, Matteo Bellone, et al.
Pharmacological Research|May 24, 2016
Long non-coding RNAs as novel therapeutic targets in cancerGiovanni Lavorgna, Riccardo Vago, Mohamad Sarmini, et al.
Leukemia|March 30, 2023
Dietary and microbiome evidence in multiple myeloma and other plasma cell disordersUrvi A Shah, Richa Parikh, Francesca Castro, et al.
Oncoimmunology|November 19, 2013
Tumor-targeting vaccination instructs graft-vs.-tumor immune responsesTeresa Manzo, Rodrigo Hess Michelini, Tabea Sturmheit, et al.
Oncoimmunology|March 14, 2013
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitorsMatteo Bellone, Arianna Calcinotto, Paola Filipazzi, et al.
Cancer Research|March 1, 2018
Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and MetastasizationCarlo Sorrentino, Stefania L Ciummo, Giuseppe Cipollone, et al.
Journal of Neuroimmunology|February 13, 2010
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulationMarianna Esposito, Francesca Ruffini, Matteo Bellone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responsesGiandomenica Iezzi, Andrea Boni, Elena Degl'Innocenti, et al.
Cancer Research|July 4, 2003
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytesAnnalisa Camporeale, Andrea Boni, Giandomenica Iezzi, et al.
Pageof 9